In 2023, the FDA and CDC's Advisory Committee on Immunization Practices (ACIP) voted in favor of recommending the monoclonal ...

For pregnant women who received the bivalent prefusion F subunit-based respiratory syncytial virus (RSV) vaccine (RSVpreF; ...

Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60. The vaccine candidates, made by ...

FDA clarifies path forward for ongoing development of Blue Lake’s industry-leading pediatric RSV vaccine Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing ...

The U.S. Food and Drug Administration expanded its approval of Moderna's respiratory syncytial virus (RSV) vaccine on Thursday to include adults under the age of 60 at increased risk of the disease.

“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the ...

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. When Laura Ehrlich gave birth to her ...

WASHINGTON -- The U.S. Food and Drug Administration has approved the first maternal vaccine intended to help protect newborns against respiratory syncytial virus (RSV). The vaccine would be given ...

COPENHAGEN, Denmark, December 22, 2022 – Bavarian Nordic A/S (BVNKF) (OMX: BAVA) announced today that the Company has completed the planned enrollment of subjects in the global, randomized, ...

The review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in protecting groups who are most at risk for serious illness, including older adults and ...

The CDC on Monday dramatically reduced the number of vaccines it recommends for all children. Here’s what parents should know ...